ToPCaP

Boston-Ireland Cancer Collaboration announces the John Fitzpatrick Fellowship programme
May 19, 2015

Boston-Ireland Cancer Collaboration announces the John Fitzpatrick Fellowship programme

A fellowship programme aimed at advancing research for new treatments in prostate cancer care has been established as part of a new collaboration between the Irish Cancer Society, Dana-Farber Cancer Institute and the Harvard School of Public Health in the United States.

The international cancer collaboration partnership was announced during the Inaugural John Fitzpatrick Irish Prostate Cancer Conference which took place in the Aviva Stadium in Dublin on 23 and 24 April 2015, in memory of Professor John Fitzpatrick, the former Head of Research at the Irish Cancer Society, marking his significant international contribution to prostate cancer research.

The cancer collaboration will bring together experts from research institutions in Ireland, and the world-renowned Dana-Farber Cancer Institute and Harvard School of Public Health, with the aim of making a significant and lasting impact on the diagnosis, treatment and management of the disease.

The partnership will create strategic relationships enhancing already established programmes and initiatives in cancer biology, epidemiology, clinical practice and population health to make a real and lasting difference to prostate cancer patients and their families on both sides of the Atlantic.

The new fellowship programme to be established as part of the collaboration will address key clinical needs in prostate cancer such as accurate diagnosis, assessment of treatment options to ensure best quality of life and identification of new therapeutic targets for treatment-resistant disease.

The selection process to identify a talented, young scientist or clinician to undertake this unique opportunity promises to be highly competitive.

The successful recipient of the award will initially spend a two year research mentorship in the world leading facilities provided by the Dana-Farber Cancer Institute and Harvard School of Public Health.

The candidate will then bring their expertise back to Ireland and integrate emerging state-of-the-art research methods into Irish prostate cancer research practice.

It is expected that the call for applications for this fellowship will open in late 2015.

- See more here.